• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

作者信息

Ploug M, Rønne E, Behrendt N, Jensen A L, Blasi F, Danø K

机构信息

Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.

出版信息

J Biol Chem. 1991 Jan 25;266(3):1926-33.

PMID:1846368
Abstract

The cellular receptor for human urokinase-type plasminogen activator (u-PAR) is shown by several independent criteria to be a true member of a family of integral membrane proteins, anchored to the plasma membrane exclusively by a COOH-terminal glycosyl-phosphatidylinositol moiety. 1) Amino acid analysis of u-PAR after micropurification by affinity chromatography and N-[2-hydroxy-1,1-bis(hydroxymethyl)-ethyl]glycine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed the presence of 2-3 mol of ethanolamine/mol protein. 2) Membrane-bound u-PAR is efficiently released from the surface of human U937 cells by trace amounts of purified bacterial phosphatidylinositol-specific phospholipase C. This soluble form of u-PAR retains the binding specificity toward both u-PA and its amino-terminal fragment holding the receptor-binding domain. 3) Treatment of purified u-PAR with phosphatidylinositol-specific phospholipase C or mild alkali completely alters the hydrophobic properties of the receptor as judged by temperature-induced detergent-phase separation and charge-shift electrophoresis. 4) Biosynthetic labeling of u-PAR was obtained with [3H]ethanolamine and myo-[3H]inositol. 5) Finally, comparison of amino acid compositions derived from cDNA sequence and amino acid analysis shows that a polypeptide of medium hydrophobicity is excised from the COOH terminus of the nascent u-PAR. A similar proteolytic processing has been reported for other proteins that are linked to the plasma membrane by a glycosyl-phosphatidylinositol membrane anchor.

摘要

相似文献

1
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
J Biol Chem. 1991 Jan 25;266(3):1926-33.
2
Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator.尿激酶型纤溶酶原激活剂细胞受体中糖基磷脂酰肌醇锚定连接的结构要求。
Eur J Biochem. 1992 Sep 1;208(2):493-500. doi: 10.1111/j.1432-1033.1992.tb17213.x.
3
N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.人尿激酶受体配体结合域的N-连接糖基化作用有助于其对配体的亲和力。
J Biol Chem. 1993 May 25;268(15):11152-9.
4
A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria.阵发性夜间血红蛋白尿患者外周血白细胞可分泌一种糖脂锚定的尿激酶型纤溶酶原激活剂受体的可溶性形式。
Eur J Biochem. 1992 Sep 1;208(2):397-404. doi: 10.1111/j.1432-1033.1992.tb17200.x.
5
Evidence for carboxyl-terminal processing and glycolipid-anchoring of human carcinoembryonic antigen.人癌胚抗原羧基末端加工及糖脂锚定的证据。
J Biol Chem. 1988 Sep 5;263(25):12716-20.
6
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
J Biol Chem. 1994 Dec 2;269(48):30682-7.
7
Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Blood Coagul Fibrinolysis. 1994 Aug;5(4):473-8.
8
Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.尿激酶氨基末端片段受体在体外建立的人表皮细胞系基质接触位点的选择性定位。
Exp Cell Res. 1992 Dec;203(2):427-34. doi: 10.1016/0014-4827(92)90017-3.
9
A surface antigen of Giardia lamblia with a glycosylphosphatidylinositol anchor.一种具有糖基磷脂酰肌醇锚定的蓝氏贾第鞭毛虫表面抗原。
J Biol Chem. 1991 Nov 5;266(31):21318-25.
10
Variant GPI structure in relation to membrane-associated functions of a murine folate receptor.与小鼠叶酸受体膜相关功能有关的糖基磷脂酰肌醇(GPI)结构变体
Biochemistry. 1996 Dec 17;35(50):16305-12. doi: 10.1021/bi961098q.

引用本文的文献

1
Soluble urokinase plasminogen activator receptor promotes endoplasmic reticulum stress and apoptosis susceptibility through RAGE in sepsis acute kidney injury.可溶性尿激酶型纤溶酶原激活物受体通过晚期糖基化终末产物受体促进脓毒症急性肾损伤中的内质网应激和凋亡易感性。
Mol Med. 2025 Sep 26;31(1):296. doi: 10.1186/s10020-025-01352-w.
2
Dynamics of the Novel Cardiac Biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF Patients Undergoing Heart Failure Therapy, a Pilot Study.射血分数降低的心力衰竭(HFrEF)患者接受心力衰竭治疗时新型心脏生物标志物sST2、H-FABP、GDF-15和可溶性尿激酶型纤溶酶原激活物受体(suPAR)的动态变化:一项初步研究
J Clin Med. 2025 Aug 11;14(16):5668. doi: 10.3390/jcm14165668.
3
Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding Entity.
新型白蛋白结合实体修饰的靶向uPAR放射性肽的设计与临床前评价
Mol Pharm. 2025 Jun 2;22(6):3242-3254. doi: 10.1021/acs.molpharmaceut.5c00135. Epub 2025 May 6.
4
CD87-targeted BiTE and CAR-T cells potently inhibit invasive nonfunctional pituitary adenomas.CD87 靶向 BiTE 和 CAR-T 细胞能有效抑制侵袭性无功能垂体腺瘤。
Sci China Life Sci. 2024 Oct;67(10):2169-2185. doi: 10.1007/s11427-024-2591-7. Epub 2024 Jul 8.
5
Clinical significance, molecular characterization, and immune microenvironment analysis of coagulation-related genes in clear cell renal cell carcinoma.透明细胞肾细胞癌中凝血相关基因的临床意义、分子特征及免疫微环境分析
Cancer Innov. 2024 Jan 7;3(1):e105. doi: 10.1002/cai2.105. eCollection 2024 Feb.
6
Role of Formyl Peptide Receptors and β-Arrestin-1 in suPAR Signal Transduction in Mouse Podocytes: Interactions with αVβ3-Integrin.形式肽受体和β-arrestin-1 在小鼠足细胞中 suPAR 信号转导中的作用:与 αVβ3-整合素的相互作用。
Cells. 2024 Jan 17;13(2):172. doi: 10.3390/cells13020172.
7
Urokinase Plasminogen Activator Receptor: An Important Focal Player in Chronic Subdural Hematoma?尿激酶型纤溶酶原激活物受体:慢性硬脑膜下血肿的重要焦点?
Inflammation. 2024 Jun;47(3):1015-1027. doi: 10.1007/s10753-023-01957-5. Epub 2024 Jan 18.
8
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.可溶性尿激酶型纤溶酶原激活物受体(suPAR)和生长分化因子-15(GDF-15)水平与成人异基因造血细胞移植受者的内皮损伤指标显著相关。
Int J Mol Sci. 2023 Dec 23;25(1):231. doi: 10.3390/ijms25010231.
9
Targeted imaging of uPAR expression in vivo with cyclic AE105 variants.用环 AE105 变体在体内靶向成像 uPAR 表达。
Sci Rep. 2023 Oct 11;13(1):17248. doi: 10.1038/s41598-023-43934-w.
10
The Fibrinolytic System and Its Measurement: History, Current Uses and Future Directions for Diagnosis and Treatment.纤维蛋白溶解系统及其检测:用于诊断和治疗的历史、当前用途和未来方向。
Int J Mol Sci. 2023 Sep 16;24(18):14179. doi: 10.3390/ijms241814179.